| P50 | author | Sebastian F Schoppmann | Q40796582 |
| | Matthias Paireder | Q61123011 |
| P2093 | author name string | Matthias Preusser | |
| | Reza Asari | |
| | Andrea Beer | |
| | Aysegül Ilhan-Mutlu | |
| | Rainer Schmid | |
| | Erwin Rieder | |
| | Gerd Jomrich | |
| | Ivan Kristo | |
| P2860 | cites work | The role of neoadjuvant and adjuvant treatment for adenocarcinoma of the upper gastrointestinal tract | Q27687612 |
| | Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey | Q30004207 |
| | Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. | Q34374229 |
| | Global incidence of oesophageal cancer by histological subtype in 2012. | Q34443765 |
| | Classification of adenocarcinoma of the oesophagogastric junction | Q34755030 |
| | Comparison of adverse effects of proton and X-ray chemoradiotherapy for esophageal cancer using an adaptive dose-volume histogram analysis. | Q35591822 |
| | Early diagnosis of oesophageal cancer. | Q37269663 |
| | Propensity score-based comparison of long-term outcomes with 3-dimensional conformal radiotherapy vs intensity-modulated radiotherapy for esophageal cancer | Q37582498 |
| | NEOSCOPE: A randomised phase II study of induction chemotherapy followed by oxaliplatin/capecitabine or carboplatin/paclitaxel based pre-operative chemoradiation for resectable oesophageal adenocarcinoma | Q37686867 |
| | Inclusion of PET-CT into planning of primary or neoadjuvant chemoradiotherapy of esophageal cancer improves prognosis. | Q38645296 |
| | Delaying surgery after neoadjuvant chemoradiotherapy does not significantly influence postoperative morbidity or oncological outcome in patients with oesophageal adenocarcinoma. | Q40773701 |
| | Total three-stage oesophagectomy for cancer of the oesophagus | Q45128613 |
| | Perioperative chemotherapy vs. neoadjuvant chemoradiation in gastroesophageal junction adenocarcinoma : A population-based evaluation of the Munich Cancer Registry | Q47716404 |
| | Neoadjuvant chemoradiotherapy plus surgery versus active surveillance for oesophageal cancer: a stepped-wedge cluster randomised trial | Q49751495 |
| | Preoperative carboplatin and paclitaxel-based chemoradiotherapy for esophageal carcinoma: results of a modified CROSS regimen utilizing radiation doses greater than 41.4 Gy. | Q51625158 |
| | Prolonged interval between neoadjuvant chemoradiotherapy and esophagectomy does not benefit the outcome in esophageal cancer: a systematic review and meta-analysis. | Q52852297 |
| | Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer | Q57259796 |
| | 7th Edition of the AJCC Cancer Staging Manual: Esophagus and Esophagogastric Junction | Q63546492 |
| | Morbidity in open versus minimally invasive hybrid esophagectomy (MIOMIE): Long-term results of a randomized controlled clinical study. | Q64911460 |
| | Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations | Q72458494 |
| | The surgical treatment of carcinoma of the oesophagus with special reference to a new operation for growths of the middle third | Q82160638 |
| | Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS trials | Q87088158 |
| | Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up | Q88406083 |
| | Neoadjuvant chemotherapy or chemoradiation for patients with advanced adenocarcinoma of the oesophagus? A propensity score-matched study | Q88426986 |
| | Neoadjuvant chemoradiotherapy for oesophageal cancer: Still looking for a challenger to the CROSS regimen | Q88585263 |
| | Outcome of Patients Treated Within and Outside a Randomized Clinical Trial on Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: Extrapolation of a Randomized Clinical Trial (CROSS) | Q89285305 |
| | Benefit of adjuvant chemotherapy based on lymph node involvement for oesophageal cancer following trimodality therapy | Q90861340 |
| P921 | main subject | esophageal cancer | Q372701 |
| P577 | publication date | 2020-02-13 | |
| P1433 | published in | Strahlentherapie und Onkologie | Q15724604 |
| P1476 | title | Modification of preoperative radiochemotherapy for esophageal cancer (CROSS protocol) is safe and efficient with no impact on surgical morbidity | |